Viewing Study NCT01943851


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-03-21 @ 6:27 PM
Study NCT ID: NCT01943851
Status: COMPLETED
Last Update Posted: 2024-10-01
First Post: 2013-09-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None leukemia View
None Acute myeloid leukemia View
None BET inhibitor View
None lymphoma View
None Myelodysplastic syndromes View
None Oncology View
None multiple myeloma View
None GSK525762 View